Friday, June 19, 2009

Call for papers for Infectious Diseases: Research and Treatment from Dr Douglas MacPherson

Dear Colleagues,

Communicating in a timely and efficient manner matters in a fast paced, high-pressure world. In few areas in medicine can the impacts of new knowledge be as significant as in infectious diseases. Novel pathogens, increased virulence, international spread are constant threats being balanced by advances in therapy, diagnostics, epidemiology, and public health management.

I invite you to submit your research communications to Infectious Diseases: Research and Treatment. Our commitments to you from the Editorial Board are to provide a timely and efficient peer review and publication process, and full open-access to your paper to ensure the broadest coverage and highest impact possible.

What is the advantage to you of publishing in Infectious Diseases: Research and Treatment?
  • Full open access: everyone can read your article and you retain copyright in it
  • Publishing decision within 2 weeks of submission
  • Your paper will not be rejected due to lack of space and will be published immediately on acceptance
  • Prompt and fair peer review from two expert peer reviewers
  • Frequent updates on your paper’s status
  • Friendly responsive staff
Aims and scope:

Infectious Diseases: Research and Treatment is a journal that publishes papers in human infectious and sexually-transmitted diseases.

What a previous author said:
"The publishing process of this journal was a most pleasant and productive experience. I was particularly impressed with the regular updates of the progress of my submission. Many other journals receive a submission and authors may not hear anything for months. I appreciate your notification policy."
In summary:

The advantages of a younger journal such as Infectious Diseases: Research and Treatment are numerous but in essence allow us a greater flexibility and responsiveness to authors and readers that older journals cannot match.

Next steps:

Yours sincerely,
Dr Douglas MacPherson

Editor-in-Chief
Infectious Diseases: Research and Treatment


0 comments: